Latest Commercialisation Strategy News

ABx Group has locked in approximately $4.1 million through a placement and fully underwritten share purchase plan, with strategic partner Good Importing International committing $1 million. The funding will support the Deep Leads rare earths project and construction and commissioning of the ALCORE pilot plant, but comes with substantial new equity and options.

InFocus Group Holdings has secured $450,000 in a placement to fund the commercialisation of its AI-driven Codexa sweepstakes casino platform, targeting the US market with new compliance technology and patent applications.

Hydrix is ramping up its defence technology efforts, focusing on sensing and autonomous systems aligned with Australia’s $425 billion 2026 National Defence Strategy. The company is developing internal prototypes and forging partnerships to commercialise intellectual property in counter-drone and ISR applications.

Omega Oil & Gas has unveiled exceptionally strong results from its Canyon-3 well, revealing a thick, high-quality oil and gas-bearing Permian interval that significantly expands the scale of its resource base in Queensland’s Taroom Trough.

Dimerix has received a US$10 million upfront payment from Everest Medicines under a regional licensing deal for DMX-200 targeting FSGS in Greater China, South Korea and Southeast Asia. This deal marks Dimerix’s fifth commercial partnership for DMX-200, collectively worth up to A$1.9 billion in milestones and royalties.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.

InFocus Group Holdings has rolled out a major upgrade to its Codexa sweepstakes casino platform, introducing a VIP-style player experience and a proprietary AI-driven compliance engine designed to streamline operations and reduce costs for white-label operators.

Iondrive Limited has independently confirmed strong rare earth recoveries from U.S. magnet waste and gained Oklahoma government support for its first commercial processing module, advancing its U.S. commercialisation strategy.

BluGlass capped FY26 with major contract wins including a $1.4 million Phase II deal with Uviquity, a $1.3 million agreement with a Fortune 500 data storage giant, and a world-record 1.9W output from its blue GaN laser, while raising $14.6 million to fuel growth.

Aurora Labs marked its commercial debut by delivering AU4 micro gas turbine propulsion systems to Sovereign Propulsion Systems, while securing a $1 million government grant to scale production and formalising a strategic defence partnership with MBDA.

LTR Pharma’s SPONTAN shows rapid absorption in Phase II interim data while securing key US commercial deals for ROXUS, setting the stage for a US market entry later this year.

dorsaVi has unveiled Sensor v6.5, its first wearable sensor that processes and acts on movement data in real time without cloud reliance, marking a key milestone in wearable Physical AI technology.